Chronic GvHD as an independent risk factor for thromboembolic complications after allogeneic stem cell transplantation

被引：0
|
作者：
Ries, I. [1 ]
Schmitt, T. [1 ]
Hauptrock, B. [1 ]
Theobald, M. [1 ]
Wagner, E. M. [1 ]
机构：
[1] UCT Univ Med Ctr, Haematol, Oncol, Pneumol, Mainz, Germany
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P313
引用
收藏
页码：S279 / S279
页数：1
相关论文
共 50 条
  • [1] Risk-factors for chronic GvHD after allogeneic haematopoietic stem cell transplantation
    Afram, G.
    Remberger, M.
    Ljungman, P.
    Ringden, O.
    Omazic, B.
    Aschan, J.
    Hagglund, H.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S113 - S113
  • [2] Antibody-mediated complications as a risk factor after allogeneic stem cell transplantation
    Watz, E.
    Remberger, M.
    Ljungman, P.
    Sundin, M.
    Mattsson, J.
    Wikman, A. Taune
    Uhlin, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S372 - S372
  • [3] Adverse environmental conditions are a risk factor for ocular GvHD after allogeneic hematopoietic stem cell transplantation
    Steven, P.
    Faust, C.
    Holtick, U.
    Scheid, C.
    Tahmaz, V.
    Stern, M. E.
    Gehlsen, U.
    BONE MARROW TRANSPLANTATION, 2020, 55 (09) : 1851 - 1853
  • [4] Adverse environmental conditions are a risk factor for ocular GvHD after allogeneic hematopoietic stem cell transplantation
    P. Steven
    C. Faust
    U. Holtick
    C. Scheid
    V. Tahmaz
    M. E. Stern
    U. Gehlsen
    Bone Marrow Transplantation, 2020, 55 : 1851 - 1853
  • [5] Efficacy of bezafibrate for chronic GVHD of the liver after allogeneic hematopoietic stem cell transplantation
    M Hidaka
    S Iwasaki
    T Matsui
    T Kawakita
    Y Inoue
    T Sakai
    N Harada
    S Takemoto
    S Nagakura
    T Kiyokawa
    M Takahashi
    T Saibara
    S Onishi
    F Kawano
    Bone Marrow Transplantation, 2010, 45 : 912 - 918
  • [6] GIANT CELL MYOCARDITIS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION - POSSIBLY CHRONIC GVHD OF THE HEART?
    Wolschke, C.
    Lellek, H.
    von Pein, U. -M.
    Alchalby, H.
    Ayuk, F.
    Schaefer, H.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S482 - S482
  • [7] Efficacy of bezafibrate for chronic GVHD of the liver after allogeneic hematopoietic stem cell transplantation
    Hidaka, M.
    Iwasaki, S.
    Matsui, T.
    Kawakita, T.
    Inoue, Y.
    Sakai, T.
    Harada, N.
    Takemoto, S.
    Nagakura, S.
    Kiyokawa, T.
    Takahashi, M.
    Saibara, T.
    Onishi, S.
    Kawano, F.
    BONE MARROW TRANSPLANTATION, 2010, 45 (05) : 912 - 918
  • [8] The risk of chronic GVHD after allogeneic blood stem cell transplantation is altered by GVHD prophylaxis and CD34+ cell dose.
    Przepiorka, D
    Anderlini, P
    Cleary, K
    Folloder, J
    Mehra, R
    Khouri, I
    Giralt, S
    Huh, YO
    Braunschweig, I
    van Besien, K
    Champlin, R
    BLOOD, 1998, 92 (10) : 457A - 457A
  • [9] Risk factors for the development of acute and chronic GVHD after allogeneic hematopoietic stem cell transplantation in children and adolescents
    Peters, C
    Lawitschka, A
    Atarbaschi, A
    Fritsch, G
    Lion, T
    Rosenmayr, A
    Fischer, G
    Hoecker, P
    Gadner, H
    Matthes-Martiin, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 49 - 49
  • [10] Risk factors for extensive chronic GvHD after allogeneic stem cell transplantation: Definition of a scoring system.
    Alessandrino, EP
    Bernasconi, P
    Colombo, AA
    Caldera, D
    Varettoni, M
    Malcovati, L
    Mangiacavalli, S
    Bonfichi, M
    Pascutto, C
    Lazzarino, M
    Bernasconi, C
    BLOOD, 2001, 98 (11) : 397A - 397A
12345